.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Colorcon
Harvard Business School
Argus Health
US Department of Justice
Moodys
Deloitte
AstraZeneca
Fuji
Baxter

Generated: June 23, 2017

DrugPatentWatch Database Preview

HUMALOG MIX 75/25 PEN Drug Profile

« Back to Dashboard

Which patents cover Humalog Mix 75/25 Pen, and what generic Humalog Mix 75/25 Pen alternatives are available?

Humalog Mix 75/25 Pen is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HUMALOG MIX 75/25 PEN is insulin lispro protamine recombinant; insulin lispro recombinant. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.

Summary for Tradename: HUMALOG MIX 75/25 PEN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list312
Drug Prices:see details
DailyMed Link:HUMALOG MIX 75/25 PEN at DailyMed

Pharmacology for Tradename: HUMALOG MIX 75/25 PEN

Ingredient-typeInsulin
Drug ClassInsulin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
HUMALOG MIX 75/25 PEN
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021017-003Dec 22, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Chubb
Julphar
Medtronic
McKesson
Queensland Health
US Army
Colorcon
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot